| Period Ending | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 |
|---|
|
Total Revenue
|
5,475,000
|
5,485,000
|
5,363,000
|
5,404,000
| | Cost of Revenue | 2,634,000 | 2,565,000 | 2,499,000 | 2,474,000 | | |
Gross Profit
|
2,841,000
|
2,920,000
|
2,864,000
|
2,930,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 929,000 | 926,000 | 918,000 | 919,000 |
|
Non Recurring | 31,000 | 17,000 | 32,000 | 21,000 |
|
Others | 821,000 | 808,000 | 820,000 | 850,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,060,000
|
1,169,000
|
1,094,000
|
1,140,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (1,000) | 4,000 | 496,000 |
-
|
|
Earnings Before Interest And Taxes | 1,059,000 | 1,173,000 | 1,590,000 | 1,140,000 |
|
Interest Expense | 398,000 | 402,000 | 402,000 | 397,000 |
|
Income Before Tax | 661,000 | 771,000 | 1,188,000 | 743,000 |
|
Income Tax Expense | 260,000 | 257,000 | 379,000 | 290,000 |
|
Minority Interest |
-
| (1,000) | (1,000) | (1,000) |
|
|
|
Net Income From Continuing Ops | 401,000 | 513,000 | 808,000 | 452,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
401,000
|
513,000
|
808,000
|
452,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
401,000
|
513,000
|
808,000
|
452,000
|
|
0.09%